XML 22 R11.htm IDEA: XBRL DOCUMENT
v3.19.2

4. Intangible Assets, Goodwill and Other | 6 Months Ended
--- | ---
Jun. 30, 2019
Goodwill and Intangible Assets Disclosure [Abstract] |
Goodwill and Intangible Assets Disclosure | GOODWILL AND OTHER PURCHASED INTANGIBLE ASSETS Changes to goodwill by segment were as follows (in millions):
| Life Science |  | Clinical Diagnostics |  | Total
Balances as of December 31, 2018: |  |  |  |  |
Goodwill | $ | 234.5 |  |  | $ | 320.5 |  |  | $ | 555.0 |
Accumulated impairment losses | (41.8 | ) |  | (293.4 | ) |  | (335.2 | )
Goodwill, net | 192.7 |  |  | 27.1 |  |  | 219.8 |
Acquisitions | 15.6 |  |  | — |  |  | 15.6 |
Balances as of June 30, 2019: |  |  |  |  |
Goodwill | 250.1 |  |  | 320.5 |  |  | 570.6 |
Accumulated impairment losses | (41.8 | ) |  | (293.4 | ) |  | (335.2 | )
Goodwill, net | $ | 208.3 |  |  | $ | 27.1 |  |  | $ | 235.4 |
In conjunction with the purchase of all the issued and outstanding stock of a small private company in March 2019 (see Note 2, "Acquisitions"), we recorded $15.6 million of goodwill that included workforce and time-to-market advantage, $5.5 million of Developed product technology, a definite-lived intangible asset, and $0.2 million of In-process research and development, an indefinite-lived intangible asset. Information regarding our identifiable purchased intangible assets with definite and indefinite lives is as follows (in millions):
| June 30, 2019
| Average Remaining Life (years) |  | Purchase Price |  | Accumulated Amortization |  | Net Carrying Amount
Customer relationships/lists | 1-6 |  | $ | 88.4 |  |  | $ | (71.2 | ) |  | $ | 17.2 |
Know how | 1-7 |  | 189.8 |  |  | (161.4 | ) |  | 28.4 |
Developed product technology | 1-10 |  | 135.5 |  |  | (89.8 | ) |  | 45.7 |
Licenses | 6-10 |  | 76.2 |  |  | (42.6 | ) |  | 33.6 |
Tradenames | 2-5 |  | 3.9 |  |  | (3.4 | ) |  | 0.5 |
Covenants not to compete | 7 |  | 3.1 |  |  | (1.2 | ) |  | 1.9 |
Total definite-lived intangible assets |  |  | $ | 496.9 |  |  | $ | (369.6 | ) |  | $ | 127.3 |
In-process research and development |  |  | 0.2 |  |  | — |  |  | 0.2 |
Total purchased intangible assets |  |  | $ | 497.1 |  |  | $ | (369.6 | ) |  | $ | 127.5 |
| December 31, 2018
| Average Remaining Life (years) |  | Purchase Price |  | Accumulated Amortization |  | Net Carrying Amount
Customer relationships/lists | 1-6 |  | $ | 88.7 |  |  | $ | (68.3 | ) |  | $ | 20.4 |
Know how | 1-7 |  | 190.6 |  |  | (159.8 | ) |  | 30.8 |
Developed product technology | 1-10 |  | 130.4 |  |  | (86.6 | ) |  | 43.8 |
Licenses | 7-11 |  | 76.3 |  |  | (40.9 | ) |  | 35.4 |
Tradenames | 2-6 |  | 3.9 |  |  | (3.3 | ) |  | 0.6 |
Covenants not to compete | 7 |  | 3.2 |  |  | (1.1 | ) |  | 2.1 |
Total definite-lived intangible assets |  |  | $ | 493.1 |  |  | $ | (360.0 | ) |  | $ | 133.1 |
Amortization expense related to purchased intangible assets is as follows (in millions):
| Three Months Ended |  | Six Months Ended
| June 30, |  | June 30,
| 2019 |  | 2018 |  | 2019 |  | 2018
Amortization expense | $ | 5.6 |  |  | $ | 7.4 |  |  | $ | 11.1 |  |  | $ | 14.8 |

X
- References No definition available. + Details
Name: | us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for goodwill and intangible assets. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 350 -URI http://asc.fasb.org/topic&trid=2144416 + Details
Name: | us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration